HeathIndustryReports

  Cardiac Biomarkers Market The key factors that drive the cardiac biomarkers market are the increasing prevalence of cardiovascular diseases and lifestyle diseases, increasing prevalence of cardiovascular diseases and lifestyle diseases, increase in demand for disease-specific treatment & research in which cardiac biomarkers are used, technological advancements in cardiac biomarkers, and favorable government initiatives to create awareness related to cardiovascular diseases. However, a lack of awareness among people is expected to hamper market growth. The global  cardiac biomarkers market  is expected to register a  CAGR of 16.36%  during the forecast period and is expected to hit  USD 4236.02 Million by 2027 . There are a number of factors that impact the growth of the cardiac biomarkers market. Some of the key factors include a rise in demand for diagnostic and testing of various cardiovascular diseases, development and adva...

  Micro Guide Catheters Market Increased development in diagnostic and minimally invasive therapies is pushing the development of micro guide catheters. Market reports associated with the medical device industry have been made accessible by Market Research Future which produces reports on other industry verticals that summaries the recent market scenarios. The market is projected to achieve  CAGR of 8%  in the forecast period. The traction for micro guide catheters is gaining momentum currently as procedures that involve the use of minimally invasive device.  Micro guide catheters market  is boosted by the growing incidence of cardiovascular and urological diseases globally. The market for micro guide catheters is expected to expand substantially as the catheters guarantee a great deal of safety and efficiency in the high-risk procedures. The reduced recovery time ensured by micro guide catheters is expected to further impel the development of the market in the ...

  Artificial insemination Market Artificial insemination involves depositing sperm into the uterus. In vitro fertilization (IVF) involves extracting the patient's egg cells to be fertilized in a lab. The resultant embryo is then transferred to the uterus. The reimbursement of these techniques is interrelated. Artificial insemination costs hundreds of dollars, while IVF costs thousands. Most of the countries in North America and Europe have a high adoption of treatments related to fertility. The number of cycles of artificial insemination covered differs depending on the country. Global  Artificial Insemination Market  is expected to register a  CAGR of 8.56%  during the forecast period and is expected to hit  USD 3,409.75 Million by 2027 . The province of New Brunswick, Canada, allows individuals to claim up to 50 percent of eligible costs incurred for IVF or IUI and related drugs, up to a maximum of USD 5,000. In France, up to four cycles of ART in wo...

  Proteomics Market Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. The Global  Proteomics Market  is anticipated to hold a market value of  USD 108907.44 million in 2030  and is expected to grow at a CAGR of 16.30% during the forecast period. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the develop...

  Viral Vector Manufacturing Market Viral vector manufacturing refers to the production of a carrier called a vector which is genetically engineered to deliver the gene because they can deliver the new gene by infecting the cell.  Considered as a drug substance, viral vectors are used in gene therapy and vaccinology (vaccines). In the case of cell therapies, the scrutiny for testing for adventitious agents is high. Viruses that are often used as vectors include retroviruses that integrate their genetic material including the new gene in the human cell, and adenoviruses, that introduce their DNA into the nucleus of the cell without letting the DNA to integrate into a chromosome. These viruses are modified so they can't cause disease when used in people. Gene therapy has seen various clinical advancement, and along with it, the viral vector manufacturing market is growing pervasively. Gene therapy is one of the most preferred treatment options for a number of chronic diseases. O...

  Artificial Intelligence in Healthcare Market The  Healthcare Artificial Intelligence Market  is expected to grow at a CAGR of 51.9% and reach USD 12 Billion by the end of the forecast period. The growing desire to reduce healthcare expenses, as well as increases in processing power and lower hardware costs, boost the healthcare artificial intelligence market. An increase in the number of collaborations and partnerships between various domains in the healthcare ecosystem, as well as a greater need to improve the quality of healthcare services as a result of the disconnect between patients and health workers. Artificial intelligence allows doctors to use tools that help them diagnose and treat patients more accurately and quickly. However, doctors are hesitant to embrace modern technology, despite patients' increasing preference for them over in-person therapy. With this issue posing a threat to the doctor-patient connection and doctors' reluctance to use AI technology, t...

  EClinical Solutions Market The global  eClinical Solutions Market  is expected to have a market value of USD 13,209.14 million by 2027. The eClinical Solutions Market suffered immensely because pet owners and farmers were encouraged to keep their animals at home. They were advised against taking their pets to the vet to get strong and effective vaccines like the Pfizer veterinary vaccines. Growth in the veterinary/eClinical Solutions Market is starting to pick up dramatically now that a vaccine for COVID-19 is being widely administered. Demand for animal vaccines is surging because livestock on farms around the world need these to remain healthy. Major Key Players: Some of the key players operating in the eClinical Solutions Market are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Ceva Santé Animale (France), Merck & Co., Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Phibro Animal Health Corporation (US), Hipra (Spain), B...

  Injection Pen Market The global  injection pen market  is expected to exhibit a strong 6.5% CAGR over the forecast period, according to the latest market research report from Market Research Future (MRFR). The global injection pen market is mainly driven by the growing prevalence of chronic diseases requiring frequent injections and the growing awareness about the availability and benefits of injection pens over the conventional vial and syringe system. The report profiles the major factors affecting the global injection pen market to pinpoint the major drivers and restraints affecting the market and presents a detailed analysis of how the market is likely to grow over the forecast period. The growing prevalence of chronic diseases such as diabetes and osteoporosis is likely to drive the global injection pen market over the forecast period. Insulin injections are a major application channel for the global injection pen market and are likely to retain their position as s...

  Biobanking Market Biobanking Market  will grow at CAGR of 6.4% to hit $ 70,250.55 Million by 2030 Factors such as the increasing prevalence of chronic diseases and rising therapeutics demand are estimated to drive the market growth during the forecast period. Additionally, advancements in diagnostic and treatment technologies boost the market. However, low awareness and lack of healthcare services in the middle and low-income countries are estimated to restrain the market growth during the projected period. Major Key Players: Some of the key players in this market are Hamilton Company, Greiner Holding AG, Promega Corporation, Becton Dickinson and Company, Merck KGaA, VWR Corporation, Tecan Trading AG, Thermo Fisher Scientific Inc., Panasonic Healthcare Holdings Co., Ltd, Qiagen N.V., Brooks Automation, Inc., Chart Industries, Inc., and others. Segment Analysis The global biobanking market is segmented on the basis of products and services, sample type, storage type, applicat...

  Oligonucleotide Synthesis Market The global  oligonucleotide synthesis market , as per the reports of Market Research Future (MRFR) is all set to rise by 10.3% CAGR during the forecast period. The market over the review period is also expected to earn substantial valuation. The chemical synthesis of the nucleic acids with definite chemical structures is known as oligonucleotide synthesis. Its ability to produce results regarding customized nucleotides rapidly through inexpensive methods is making it choicest preference for a lot of research laboratories that are spending heavily in developing biotechnologies. The desired oligonucleotide requires a perfect oligonucleotide chain which can easily be made in laboratories. The completion of the chain sees a release from the solid phase to the solution, deprotected, and collected. MRFR in their recent report on the oligonucleotide synthesis market distinctly studied segments with their proper valuation both value-wise and volume-w...

  Gene Therapy Market Gene therapy is a technique in which a piece of DNA is incorporated into the cell via a vector. The key players are investing in the manufacturing of cell and gene therapy treatments due to its target specificity. The gene therapy is mainly of two types, somatic gene therapy, and germline gene therapy, depending on the type of cells its targets. According to MRFR analysis, the global  gene therapy market  is expected to register a  CAGR of 40.7%  during the forecast period and was valued at USD 524 million in 2018. The growth of the global gene therapy market is attributed to various factors such as robust product pipeline, increasing investment by key players, and high prevalence of target diseases and demand for innovative medication. However, the high cost of product development and stringent regulatory policies are expected to curb the growth of the global gene therapy market. The global gene therapy market is currently dominated b...

  Durable Medical Equipment Market Durable Medical Equipment or home medical equipment provides therapeutic benefits to patients. They are easy to use and does not need any special skill or training thus can easily be managed by a caretaker or a family member of the patient. Increasing per capita income, healthcare expenditure and aging population in Middle East and Africa are driving the DME market’s growth. The Middle-East and Africa  Durable Medical Equipment Market  has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. The Middle East and Africa healthcare sector is growing by 10% annually and it comprise 2% of the total global healthcare expenditure. Huge Investment in R&D by DME manufacturers are leading to more innovative product development. Developing infrastructure, government initiatives, extended insurance coverage and increasing awareness are major drivers of this market. ...

  Healthcare Regulatory Affairs Outsourcing Market The healthcare regulatory affairs outsourcing offers medical writing and publishing which plays an important role to develop high-quality documents for the clinical research process. The rising, increasing number of patent expirations and growing research and development activities are some factors that are likely to propel the market growth during the assessment period. Market Research Future (MRFR) announces the publication of its research report –Global  Healthcare Regulatory Affairs Outsourcing Market  . The global Healthcare Regulatory Affairs Outsourcing Market held a market value of USD 3,120.4 million in 2017 and is projected to grow at a  CAGR of 9.4%  over the forecast period. Additionally, the rising incidence of several chronic diseases such as cancer and other infectious diseases have encouraged biopharmaceutical companies to develop a large number of new products. This rising development of product...